Breaking the Bottleneck: How Verseon is Rewriting the Future of Drug Discovery Beyond Pharma's Limits

Fonte: International Business Times

For over a century, the pharmaceutical industry has been bound by a paradox: billions of dollars are poured into research and development every year, yet effective treatments for too many of the world's most devastating diseases remain elusive. According to the research, only less than 10% of drugs entering clinical trials ever reach the market. This staggering inefficiency underscores why, despite remarkable advances in biology and medicine, most diseases still lack adequate treatments.